PDS5B and glioblastoma: To further evaluate the potential therapeutic value of lncRNA HOXA‐AS3 inhibition in vivo, we transfected shRNA lncRNA HOXA‐AS3 plasmid vectors into LN229 cells (sh‐HOXA‐AS3/LN229) for orthotopic GBM xenografts.